Mitochondrial pharmacology.

[1]  M. Duchen,et al.  Roles of mitochondria in human disease. , 2010, Essays in biochemistry.

[2]  I. Tucker,et al.  Effect of cyclosporin A on the pharmacokinetics of mitoquinone (MitoQ 10 ), a mitochondria-targeted antioxidant, in rat , 2010 .

[3]  Eva Pebay-Peyroula,et al.  Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside , 2003, Nature.

[4]  A. Garnier,et al.  Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. , 2008, Cardiovascular research.

[5]  L. MacMillan-Crow,et al.  The Mitochondria-Targeted Antioxidant Mitoquinone Protects against Cold Storage Injury of Renal Tubular Cells and Rat Kidneys , 2011, Journal of Pharmacology and Experimental Therapeutics.

[6]  J. Joseph,et al.  Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. , 2005, Free radical biology & medicine.

[7]  Robin A. J. Smith,et al.  Mitochondria-targeted small molecule therapeutics and probes. , 2011, Antioxidants & redox signaling.

[8]  R. Youle,et al.  Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. , 2011, Antioxidants & redox signaling.

[9]  M. Murphy,et al.  Mitochondria--a neglected drug target. , 2009, Current opinion in investigational drugs.

[10]  T. Tomizaki,et al.  The Whole Structure of the 13-Subunit Oxidized Cytochrome c Oxidase at 2.8 Å , 1996, Science.

[11]  L. A. Obukhova,et al.  An attempt to prevent senescence: a mitochondrial approach. , 2009, Biochimica et biophysica acta.

[12]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[13]  Rouslan G. Efremov,et al.  The architecture of respiratory complex I , 2010, Nature.

[14]  D. Harrison,et al.  Therapeutic targeting of mitochondrial superoxide in hypertension , 2010, Circulation research.

[15]  B. Hohenester.  A therapy for myopathy caused by collagen VI mutations? , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[16]  M. Brand,et al.  Mitochondrial uncoupling as a target for drug development for the treatment of obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[17]  Manuela G. López,et al.  Mitochondrial Na+/Ca2+-Exchanger Blocker CGP37157 Protects against Chromaffin Cell Death Elicited by Veratridine , 2009, Journal of Pharmacology and Experimental Therapeutics.

[18]  D. Green,et al.  Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging , 2011, Science.

[19]  E. Elmér,et al.  The Nonimmunosuppressive Cyclosporin Analogs NIM811 and UNIL025 Display Nanomolar Potencies on Permeability Transition in Brain-Derived Mitochondria , 2004, Journal of bioenergetics and biomembranes.

[20]  L. Guarente,et al.  A therapeutic role for sirtuins in diseases of aging? , 2007, Trends in biochemical sciences.

[21]  H. Szeto,et al.  Novel Therapies Targeting Inner Mitochondrial Membrane—From Discovery to Clinical Development , 2011, Pharmaceutical Research.

[22]  Robin A. J. Smith,et al.  The mitochondria‐targeted anti‐oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[23]  B. Teicher,et al.  Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractionated X rays. , 1987, International Journal of Radiation Oncology, Biology, Physics.

[24]  A. Munnich,et al.  Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study , 1999, The Lancet.

[25]  H. Jacobs,et al.  Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restriction , 2010, Proceedings of the National Academy of Sciences.

[26]  D. Wallace,et al.  Mitochondrial energetics and therapeutics. , 2010, Annual review of pathology.

[27]  H. Ke,et al.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases , 2012, Cell.

[28]  P. Bernardi,et al.  Therapy of collagen VI-related myopathies (Bethlem and Ullrich) , 2008, Neurotherapeutics.

[29]  D. Rubinsztein,et al.  Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. , 2010, Free radical biology & medicine.

[30]  C. Mammucari,et al.  Molecules and roles of mitochondrial calcium signaling. , 2011, BioFactors.

[31]  R. Moreno-Sánchez,et al.  Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II* , 2010, The Journal of Biological Chemistry.

[32]  R. Bersin,et al.  Dichloroacetate as metabolic therapy for myocardial ischemia and failure. , 1997, American heart journal.

[33]  J. Eisenbart,et al.  Mitochondrial complex III ROS regulate adipocyte differentiation. , 2011, Cell metabolism.

[34]  S. Girardin,et al.  Mitochondria in innate immunity , 2011, EMBO reports.

[35]  Sang-Bing Ong,et al.  Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury , 2010, Circulation.

[36]  S. Kelley,et al.  Maximizing the therapeutic window of an antimicrobial drug by imparting mitochondrial sequestration in human cells. , 2011, Journal of the American Chemical Society.

[37]  M. Brand,et al.  CONTROL OF ELECTRON FLUX THROUGH THE RESPIRATORY CHAIN IN MITOCHONDRIA AND CELLS , 1987, Biological reviews of the Cambridge Philosophical Society.

[38]  M. Crompton,et al.  Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation , 2009, The Biochemical journal.

[39]  A. Halestrap,et al.  A pore way to die , 2005 .

[40]  Robin A. J. Smith,et al.  Animal and human studies with the mitochondria‐targeted antioxidant MitoQ , 2010, Annals of the New York Academy of Sciences.

[41]  D. Rideout,et al.  A self-assembling protein kinase C inhibitor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Pengfei Wang,et al.  Mitochondria-targeting properties and photodynamic activities of porphyrin derivatives bearing cationic pendant. , 2010, Journal of photochemistry and photobiology. B, Biology.

[43]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[44]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[45]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[46]  S. Kelley,et al.  Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications , 2009, Chembiochem : a European journal of chemical biology.

[47]  Michael Erb,et al.  NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels , 2011, PloS one.

[48]  E. Schon,et al.  In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis , 2011, Cell metabolism.

[49]  Paolo Bernardi,et al.  Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. , 2011, Cell calcium.

[50]  J. Vissing,et al.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy , 2007, Journal of Neurology.

[51]  Linda Partridge,et al.  Unraveling the biological roles of reactive oxygen species. , 2011, Cell metabolism.

[52]  S. Kalivendi,et al.  Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. , 2010, Free radical biology & medicine.

[53]  P. Bonaldo,et al.  Autosomal recessive myosclerosis myopathy is a collagen VI disorder , 2008, Neurology.

[54]  Edward T Chouchani,et al.  A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury , 2009, Proceedings of the National Academy of Sciences.

[55]  M. Brand,et al.  Mitochondrial uncouplers with an extraordinary dynamic range. , 2007, The Biochemical journal.

[56]  A. Schapira,et al.  Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects , 2000, The Lancet.

[57]  T. Kuwana,et al.  Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. , 2008, Developmental cell.

[58]  Rutger O. Vogel,et al.  Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. , 2009, American journal of human genetics.

[59]  S. Kelley,et al.  Mitochondria‐Penetrating Peptides: Sequence Effects and Model Cargo Transport , 2009, Chembiochem : a European journal of chemical biology.

[60]  P. Chinnery,et al.  The inheritance of pathogenic mitochondrial DNA mutations , 2009, Biochimica et biophysica acta.

[61]  B. Chance,et al.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Robin A. J. Smith,et al.  Targeting antioxidants to mitochondria by conjugation to lipophilic cations. , 2007, Annual review of pharmacology and toxicology.

[63]  D. Menon,et al.  Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes. , 2010, Biochimica et biophysica acta.

[64]  V. Mootha,et al.  The mitochondrial proteome and human disease. , 2010, Annual review of genomics and human genetics.

[65]  T. A. Link,et al.  Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. , 1998, Science.

[66]  L. Gluud,et al.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. , 2012, The Cochrane database of systematic reviews.

[67]  Z. Rao,et al.  Crystal Structure of Mitochondrial Respiratory Membrane Protein Complex II , 2005, Cell.

[68]  M. Ryan,et al.  Assembly factors of human mitochondrial complex I and their defects in disease , 2010, IUBMB life.

[69]  R. Hartley,et al.  Selective Uncoupling of Individual Mitochondria within a Cell Using a Mitochondria-Targeted Photoactivated Protonophore , 2011, Journal of the American Chemical Society.

[70]  D. Bers,et al.  Mitochondria: from basic biology to cardiovascular disease. , 2009, Journal of molecular and cellular cardiology.

[71]  H. Atamna,et al.  Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase. , 2010, Journal of Alzheimer's disease : JAD.

[72]  L. Partridge,et al.  Measurement of H2O2 within Living Drosophila during Aging Using a Ratiometric Mass Spectrometry Probe Targeted to the Mitochondrial Matrix , 2011, Cell metabolism.

[73]  M. Ristow,et al.  Small‐Molecule Targeting of the Mitochondrial Compartment with an Endogenously Cleaved Reversible Tag , 2009, Chembiochem : a European journal of chemical biology.

[74]  S. Rodríguez-Enríquez,et al.  Selective degradation of mitochondria by mitophagy. , 2007, Archives of biochemistry and biophysics.

[75]  B. Spiegelman,et al.  Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. , 2008, Cell metabolism.

[76]  M. Zeviani,et al.  Expression of the Ciona intestinalis alternative oxidase (AOX) in Drosophila complements defects in mitochondrial oxidative phosphorylation. , 2009, Cell metabolism.

[77]  N. Jhala,et al.  Mitochondria‐targeted ubiquinone (MitoQ) decreases ethanol‐dependent micro and macro hepatosteatosis , 2011, Hepatology.

[78]  L. Galluzzi,et al.  Targeting mitochondria for cancer therapy , 2010, Nature Reviews Drug Discovery.

[79]  J. Franklin,et al.  The Mitochondria-Targeted Antioxidant MitoQ Prevents Loss of Spatial Memory Retention and Early Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[80]  E. Murphy,et al.  What makes the mitochondria a killer? Can we condition them to be less destructive? , 2011, Biochimica et biophysica acta.

[81]  Gene Kim,et al.  Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. , 2009, The Journal of clinical investigation.

[82]  G. Feher,et al.  Crystallization and X-ray structure determination of cytochrome c2 from Rhodobacter sphaeroides in three crystal forms. , 1995, Acta crystallographica. Section D, Biological crystallography.

[83]  R. Lightowlers,et al.  Progress and prospects: gene therapy for mitochondrial DNA disease , 2008, Gene Therapy.

[84]  Robin A. J. Smith,et al.  Synthesis and Characterization of a Triphenylphosphonium-conjugated Peroxidase Mimetic , 2005, Journal of Biological Chemistry.

[85]  C. Angelini,et al.  Mitochondrial disorders of the nuclear genome. , 2009, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[86]  R. Tompkins,et al.  Novel Mitochondria-Targeted Antioxidant Peptide Ameliorates Burn-Induced Apoptosis and Endoplasmic Reticulum Stress in the Skeletal Muscle of Mice , 2011, Shock.

[87]  V. Skulachev,et al.  Penetrating cation/fatty acid anion pair as a mitochondria-targeted protonophore , 2009, Proceedings of the National Academy of Sciences.

[88]  P. Chinnery,et al.  Mitochondrial myopathies: developments in treatment. , 2010, Current opinion in neurology.

[89]  N. Neamati,et al.  Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity , 2010, PloS one.

[90]  S. Dimauro,et al.  The genetics and pathology of oxidative phosphorylation , 2001, Nature Reviews Genetics.

[91]  A. Leslie,et al.  On the structure of the stator of the mitochondrial ATP synthase , 2006, The EMBO journal.

[92]  C. Reggiani,et al.  Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency , 2003, Nature Genetics.

[93]  J. Auwerx,et al.  Regulation of PGC-1 a , a nodal regulator of mitochondrial biogenesis 1 – 4 , 2011 .

[94]  A. Ferlini,et al.  Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies , 2008, Proceedings of the National Academy of Sciences.

[95]  Edward T Chouchani,et al.  Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation , 2010, The Biochemical journal.

[96]  Shuang Liu,et al.  64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging. , 2011, Bioconjugate chemistry.

[97]  Pierre Croisille,et al.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.